You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

List of Excipients in API ONDANSETRON


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing ONDANSETRON

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Fortovia Therapeutics Inc ZUPLENZ ondansetron 89141-444 AMMONIUM GLYCYRRHIZATE
Fortovia Therapeutics Inc ZUPLENZ ondansetron 89141-444 BUTYLATED HYDROXYTOLUENE
Fortovia Therapeutics Inc ZUPLENZ ondansetron 89141-444 CALCIUM CARBONATE
Fortovia Therapeutics Inc ZUPLENZ ondansetron 89141-444 ERYTHRITOL
Fortovia Therapeutics Inc ZUPLENZ ondansetron 89141-444 HYPROMELLOSE
Fortovia Therapeutics Inc ZUPLENZ ondansetron 89141-444 PEPPERMINT
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Get Started Free

Excipients in ANDA-approved (generic) drugs containing ONDANSETRON

Company Ingredient NDC Excipient
West-Ward Pharmaceuticals Corp ondansetron 0143-9890 CITRIC ACID MONOHYDRATE
West-Ward Pharmaceuticals Corp ondansetron 0143-9890 METHYLPARABEN
West-Ward Pharmaceuticals Corp ondansetron 0143-9890 PROPYLPARABEN
West-Ward Pharmaceuticals Corp ondansetron 0143-9890 SODIUM CHLORIDE
West-Ward Pharmaceuticals Corp ondansetron 0143-9890 TRISODIUM CITRATE DIHYDRATE
West-Ward Pharmaceuticals Corp ondansetron 0143-9890 WATER
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Get Started Free

Detailed excipient profiles for ONDANSETRON

Excipient focus: ACETIC ACID

Excipient focus: AMMONIUM GLYCYRRHIZATE

Excipient focus: ANHYDROUS CITRIC ACID

Excipient focus: ANHYDROUS LACTOSE

Excipient focus: ASPARTAME

Excipient focus: BUTYLATED HYDROXYTOLUENE

Excipient focus: CALCIUM CARBONATE

Excipient focus: CALCIUM STEARATE

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CITRIC ACID MONOHYDRATE

Excipient focus: COLLOIDAL SILICON DIOXIDE

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: CROSPOVIDONE

Excipient focus: DEXTROSE

Excipient focus: EDETATE DISODIUM

Excipient focus: ERYTHRITOL

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: GLYCERIN

Excipient focus: GLYCERYL DISTEARATE

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSES

Excipient focus: LACTOSE

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: LACTOSE, ANHYDROUS

Excipient focus: LECITHIN, SOYBEAN

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MALTODEXTRIN

Excipient focus: MANNITOL

Excipient focus: METHYLPARABEN

Excipient focus: PEPPERMINT

Excipient focus: POLACRILIN POTASSIUM

Excipient focus: POLYDEXTROSE

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POLYETHYLENE GLYCOLS

Excipient focus: POLYSORBATE 80

Excipient focus: POLYVINYL ALCOHOL

Excipient focus: PROPYLENE GLYCOL

Excipient focus: PROPYLPARABEN

Excipient focus: SACCHARIN SODIUM

Excipient focus: SACCHARIN SODIUM ANHYDROUS

Excipient focus: SACCHARIN SODIUM DIHYDRATE

Excipient focus: SAND

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM BENZOATE

Excipient focus: SODIUM BICARBONATE

Excipient focus: SODIUM CHLORIDE

Excipient focus: SODIUM CITRATE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

Excipient focus: SODIUM STEARYL FUMARATE

ONDANSETRON drug variants containing SODIUM STEARYL FUMARATE

Company Ingredient NDC
Mylan Pharmaceuticals Inc ondansetron 0378-7732
HHS/Program Support Center/Supply Service Center ondansetron 11819-365
United States Department of Health & Human Services ondansetron 11819-371
Aidarex Pharmaceuticals LLC ondansetron 33261-747
Lake Erie Medical DBA Quality Care Products LLC ondansetron 35356-678
Rebel Distributors Corp ondansetron 42254-212
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: SORBITOL

Excipient focus: STARCH, CORN

Excipient focus: STRAWBERRY

Excipient focus: SUCRALOSE

Excipient focus: SUCROSE

ONDANSETRON drug variants containing SUCROSE

Company Ingredient NDC
NorthStar Rx LLC ondansetron hydrochloride 16714-671
ATLANTIC BIOLOGICALS CORP ondansetron hydrochloride 17856-0555
Atlantic Biologics Corp ondansetron hydrochloride 17856-0672
RPK Pharmaceuticals Inc ondansetron hydrochloride 53002-1633
Lannett Company Inc ondansetron hydrochloride 54838-555
Chartwell RX LLC ondansetron hydrochloride 62135-555
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TRIACETIN

Excipient focus: TRISODIUM CITRATE DIHYDRATE

ONDANSETRON drug variants not containing TRISODIUM CITRATE DIHYDRATE

Company Ingredient NDC
Mylan Pharmaceuticals Inc ondansetron 0378-0315
Mylan Pharmaceuticals Inc ondansetron 0378-7732
Major Pharmaceuticals ondansetron 0904-7073
HHS/Program Support Center/Supply Service Center ondansetron 11819-365
United States Department of Health & Human Services ondansetron 11819-371
NorthStar Rx LLC ondansetron 16714-159
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: WATER

Excipient focus: XANTHAN GUM

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
 NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links